...
首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
【24h】

Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.

机译:MSI-H大肠癌的分子特征通过MLHI启动子甲基化,免疫组织化学和错配修复种系突变筛选来表征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Microsatellite instability (MSI) occurs in 10% to 20% of colorectal cancers (CRC) and has been attributed to both MLH1 promoter hypermethylation and germline mutation in the mismatch repair (MMR) genes. We present results from a large population- and clinic-based study of MLH1 methylation, immunohistochemistry, and MMR germline mutations that enabled us to (a) estimate the prevalence of MMR germline mutations and MLH1 methylation among MSI-H cases and help us understand if all MSI-H CRC is explained by these mechanisms and (b) estimate the associations between MLH1 methylation and sex, age, and tumor location within the colon. MLH1 methylation was measured in 1,061 population-based and 172 clinic-based cases of CRC. Overall, we observed MLH1 methylation in 60% of population-based MSI-H cases and in 13% of clinic-based MSI-H cases. Within the population-based cases with MMR mutation screening and conclusive immunohistochemistry results, we identified a molecular event in MMR in 91% of MSI-H cases: 54% had MLH1 methylation, 14% had a germline mutation in a MMR gene, and 23% had immunohistochemistry evidence for loss of a MMR protein. We observed a striking age difference, with the prevalence of a MMR germline mutation more than 4-fold lower and the prevalence of MLH1 methylation more than 4-fold higher in cases diagnosed after the age of 50 years than in cases diagnosed before that age. We also determined that female sex is an independent predictor of MLH1 methylation within the MSI-H subgroup. These results reinforce the importance of distinguishing between the underlying causes of MSI in studies of etiology and prognosis.
机译:微卫星不稳定性(MSI)发生在10%至20%的大肠癌(CRC)中,并已归因于MLH1启动子超甲基化和错配修复(MMR)基因中的种系突变。我们提供了基于人群和诊所的MLH1甲基化,免疫组织化学和MMR生殖系突变研究的结果,这些研究使我们能够(a)估计MSI-H病例中MMR生殖系突变和MLH1甲基化的发生率,并帮助我们了解是否所有MSI-H CRC均由这些机制解释,并且(b)估计MLH1甲基化与结肠中的性别,年龄和肿瘤位置之间的关联。在1,061例基于人群和172例基于临床的CRC病例中测量了MLH1甲基化。总体而言,我们在60%的基于人群的MSI-H病例和13%的基于临床的MSI-H病例中观察到MLH1甲基化。在具有MMR突变筛查和最终免疫组化结果的基于人群的病例中,我们在91%的MSI-H病例中发现了MMR的分子事件:54%的患者患有MLH1甲基化,14%的患者具有MMR基因的种系突变,以及23 %的人有免疫组织化学证据表明MMR蛋白丢失。我们观察到了显着的年龄差异,与50岁以下年龄相比,MMR种系突变的患病率低50倍以上,MLH1甲基化的患病率高4倍以上。我们还确定,女性是MSI-H亚组内MLH1甲基化的独立预测因子。这些结果加强了在病因学和预后研究中区分MSI的根本原因的重要性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号